Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2017-05-30Clinical Trial Update: Efficacy and Safety of the Use of Memantine for Preserving Cognition in Adult Patients With Epilepsy [NA]
A clinical trial evaluating memantine for preserving cognition in adults with epilepsy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-05-03Clinical Trial Update: Remote Tracking of Epilepsy Patients
The UCSF-sponsored clinical trial NCT01130649 on remote tracking of epilepsy patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-28Clinical Trial Update: The Utility of NIOM During LITT for Refractory MTLE [NA]
The clinical trial NCT02913742 exploring NIOM during LITT for refractory mesial temporal lobe epilepsy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-27Clinical Trial Update: Mainstream Sleep Tracking Devices vs Polysomnography [NA]
A clinical trial comparing mainstream sleep tracking devices to polysomnography was withdrawn, involving obstructive sleep apnea, insomnia, …
-
CLINICAL_TRIALS withdrawal · 2017-03-13Clinical Trial Update: Pre-oxygenation and Measures of Gas Exchanges During Seizures in the Epilepsy Monitoring Unit [NA]
A clinical trial investigating pre-oxygenation and gas-exchange measurements during seizures in the Epilepsy Monitoring Unit has been termin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-10-09Clinical Trial Update: Treatment Resistant Epilepsy and N-Acetyl Cysteine [NA]
A clinical trial investigating N-Acetyl Cysteine for treatment-resistant epilepsy in autism with irritability has been withdrawn; no results…
-
CLINICAL_TRIALS withdrawal · 2015-01-08Clinical Trial Update: Effect of Music Therapy on Cognitive Recovery [NA]
A clinical trial evaluating music therapy for cognitive recovery in epilepsy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-12-10Clinical Trial Update: Study of Phenobarbital Inhibition of Catamenial Epilepsy [NA]
The study evaluating phenobarbital for catamenial epilepsy has been withdrawn from clinical trials, with no current recruitment or results a…
-
CLINICAL_TRIALS withdrawal · 2013-04-04Clinical Trial Update: GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures [Phase 2]
A Phase 2 trial evaluating GW273225 as add-on therapy for partial seizures in epilepsy was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-11-01Clinical Trial Update: Seizure Therapy With Intravenous Levetiracetam and Lorazepam [Phase 2, Phase 3]
The Phase 2/3 clinical trial evaluating intravenous levetiracetam with lorazepam for seizure therapy has been withdrawn.
-
EMA withdrawal · 2012-08-16EMA Lapsed: Exalief (eslicarbazepine acetate) — BIAL - Portela Ca, S.A.
EMA status indicates Exalief (eslicarbazepine acetate) has lapsed in Europe.
-
CLINICAL_TRIALS withdrawal · 2012-05-28Clinical Trial Update: Open Label Trial to Study the Long-term Safety and Efficacy of Seletracetam for the Treatment of Epilepsy [Phase 3]
The Phase 3 open-label trial evaluating long-term safety and efficacy of seletracetam for epilepsy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-03-20Clinical Trial Update: Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy. [Phase 3]
The Phase 3 open-label trial of Seletracetam in refractory epilepsy has been withdrawn, according to sponsor UCB Pharma.
-
EMA withdrawal · 2010-01-20EMA Application withdrawn: Comfyde (carisbamate) — Janssen-Cilag International NV
EMA withdrew the application for Comfyde (carisbamate) by Janssen-Cilag International NV in epilepsy.
-
CLINICAL_TRIALS withdrawal · 2009-02-10Clinical Trial Update: fMRI Investigation of Depression in Patients With Epilepsy
The clinical trial investigating fMRI assessment of depression in patients with epilepsy has been withdrawn.